No Data
No Data
Nyrada Submits Clinical Trial Regulatory Package for Ethics Committee Review
Nyrada Inc: Nyrada Receives A$1.235M R&D Tax Incentive Rebate
Nyrada Completes Preclinical Studies Ahead of Stroke Therapy's Phase One Trial; Shares Climb 31%
ASX Small-Cap Stocks to Watch
Nyrada Inc: Full Year Results FY2024
Nyrada Inc: Annual Report for year ended 30 June 2024
No Data
151479178 : What are you talking about